Furthermore, previous research has highlighted the role of Prkci in promoting tumor growth and metastasis in pancreatic cancer via its interaction with the kinase RIPK2, leading to increased phosphorylation of NF-κB, JNK, and ERK pathways11. Here, RIPK2 is linked to neoplasm.